Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Endothelial Cells | 40 | 2022 | 296 | 11.750 |
Why?
|
Mechanotransduction, Cellular | 31 | 2021 | 45 | 11.300 |
Why?
|
Glycocalyx | 35 | 2021 | 36 | 10.410 |
Why?
|
Endothelium, Vascular | 30 | 2021 | 229 | 6.910 |
Why?
|
Stress, Mechanical | 39 | 2021 | 110 | 5.630 |
Why?
|
Models, Cardiovascular | 19 | 2016 | 53 | 4.010 |
Why?
|
Atherosclerosis | 10 | 2022 | 131 | 3.630 |
Why?
|
Glypicans | 7 | 2021 | 8 | 3.540 |
Why?
|
Myocytes, Smooth Muscle | 10 | 2015 | 84 | 3.160 |
Why?
|
Nitric Oxide | 16 | 2021 | 287 | 2.910 |
Why?
|
Heparan Sulfate Proteoglycans | 6 | 2019 | 12 | 2.740 |
Why?
|
Aorta | 13 | 2015 | 161 | 2.620 |
Why?
|
Muscle, Smooth, Vascular | 9 | 2015 | 127 | 2.290 |
Why?
|
Shear Strength | 13 | 2017 | 23 | 2.160 |
Why?
|
Cell Movement | 7 | 2019 | 545 | 2.100 |
Why?
|
Cells, Cultured | 35 | 2021 | 1442 | 2.050 |
Why?
|
Cattle | 27 | 2016 | 472 | 2.020 |
Why?
|
Animals | 72 | 2022 | 14307 | 1.990 |
Why?
|
Lipoproteins, LDL | 7 | 2016 | 61 | 1.970 |
Why?
|
Heparitin Sulfate | 10 | 2019 | 23 | 1.880 |
Why?
|
Models, Biological | 13 | 2018 | 642 | 1.620 |
Why?
|
Syndecan-1 | 6 | 2019 | 9 | 1.570 |
Why?
|
Nitric Oxide Synthase Type III | 9 | 2021 | 63 | 1.500 |
Why?
|
Capillary Permeability | 7 | 2016 | 30 | 1.490 |
Why?
|
Extracellular Fluid | 3 | 2019 | 13 | 1.450 |
Why?
|
Glycosaminoglycans | 6 | 2018 | 22 | 1.370 |
Why?
|
Lysophospholipids | 6 | 2018 | 19 | 1.310 |
Why?
|
Rats | 26 | 2021 | 3261 | 1.220 |
Why?
|
Arteries | 6 | 2020 | 67 | 1.210 |
Why?
|
Matrix Metalloproteinase 1 | 3 | 2011 | 22 | 1.130 |
Why?
|
Gene Expression Regulation | 5 | 2019 | 968 | 1.110 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 3 | 2011 | 97 | 1.100 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 3 | 2011 | 94 | 1.090 |
Why?
|
Sphingosine | 5 | 2018 | 21 | 1.050 |
Why?
|
Endothelium | 3 | 2016 | 31 | 1.040 |
Why?
|
Integrins | 3 | 2019 | 49 | 0.950 |
Why?
|
Water | 9 | 2023 | 283 | 0.940 |
Why?
|
Fibroblasts | 3 | 2011 | 252 | 0.930 |
Why?
|
Computer Simulation | 7 | 2017 | 347 | 0.920 |
Why?
|
Blood Flow Velocity | 9 | 2015 | 63 | 0.920 |
Why?
|
Aorta, Thoracic | 6 | 2016 | 24 | 0.900 |
Why?
|
Biological Transport | 12 | 2018 | 175 | 0.890 |
Why?
|
Neoplasm Metastasis | 3 | 2019 | 211 | 0.870 |
Why?
|
Astrocytes | 2 | 2022 | 203 | 0.860 |
Why?
|
Endothelin-1 | 3 | 2007 | 54 | 0.830 |
Why?
|
Hemodynamics | 10 | 2016 | 86 | 0.800 |
Why?
|
Apoptosis | 6 | 2016 | 1317 | 0.800 |
Why?
|
Vascular Diseases | 1 | 2021 | 30 | 0.790 |
Why?
|
Rheology | 5 | 2014 | 24 | 0.770 |
Why?
|
Mice | 13 | 2022 | 5668 | 0.770 |
Why?
|
Matrix Metalloproteinase 2 | 3 | 2011 | 47 | 0.750 |
Why?
|
Membrane Microdomains | 3 | 2018 | 46 | 0.740 |
Why?
|
Humans | 40 | 2022 | 34853 | 0.740 |
Why?
|
Carcinoma, Renal Cell | 2 | 2019 | 35 | 0.730 |
Why?
|
Gene Expression | 3 | 2022 | 639 | 0.720 |
Why?
|
Syndecan-4 | 1 | 2019 | 4 | 0.720 |
Why?
|
Kidney Neoplasms | 2 | 2019 | 65 | 0.720 |
Why?
|
Cell Communication | 3 | 2017 | 93 | 0.710 |
Why?
|
Pulsatile Flow | 5 | 2015 | 15 | 0.700 |
Why?
|
Epoprostenol | 2 | 2016 | 21 | 0.680 |
Why?
|
Electroosmosis | 1 | 2018 | 1 | 0.670 |
Why?
|
Stress, Physiological | 2 | 2017 | 137 | 0.650 |
Why?
|
Cyclooxygenase 2 | 2 | 2016 | 92 | 0.640 |
Why?
|
Blood Pressure | 9 | 2013 | 613 | 0.620 |
Why?
|
Coronary Vessels | 4 | 2016 | 93 | 0.610 |
Why?
|
Cytoskeleton | 4 | 2014 | 98 | 0.610 |
Why?
|
Transcription Factor RelA | 1 | 2016 | 37 | 0.590 |
Why?
|
Intercellular Junctions | 4 | 2010 | 17 | 0.560 |
Why?
|
Matrix Metalloproteinase 13 | 2 | 2013 | 5 | 0.520 |
Why?
|
Cell Line | 7 | 2018 | 1289 | 0.500 |
Why?
|
Heart Valve Prosthesis | 5 | 2005 | 17 | 0.500 |
Why?
|
Calcium Signaling | 2 | 2005 | 95 | 0.500 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 628 | 0.490 |
Why?
|
Microcirculation | 4 | 2014 | 39 | 0.490 |
Why?
|
Blood-Retinal Barrier | 2 | 2011 | 8 | 0.480 |
Why?
|
Diabetic Angiopathies | 1 | 2013 | 20 | 0.480 |
Why?
|
Membrane Fluidity | 1 | 2013 | 11 | 0.480 |
Why?
|
Cell Adhesion | 4 | 2017 | 209 | 0.460 |
Why?
|
Hyaluronic Acid | 4 | 2017 | 33 | 0.460 |
Why?
|
Chondroitin Sulfates | 4 | 2015 | 9 | 0.450 |
Why?
|
Collagen Type I | 2 | 2009 | 27 | 0.440 |
Why?
|
Heart, Artificial | 4 | 2004 | 6 | 0.440 |
Why?
|
Cell Membrane Permeability | 4 | 2018 | 49 | 0.420 |
Why?
|
Nitric Oxide Synthase | 3 | 2013 | 103 | 0.420 |
Why?
|
RNA, Small Interfering | 4 | 2021 | 391 | 0.420 |
Why?
|
Permeability | 6 | 2011 | 67 | 0.420 |
Why?
|
Albumins | 2 | 2012 | 24 | 0.410 |
Why?
|
Pressure | 8 | 2010 | 36 | 0.410 |
Why?
|
Polysaccharide-Lyases | 5 | 2015 | 10 | 0.410 |
Why?
|
Extracellular Matrix | 1 | 2012 | 111 | 0.400 |
Why?
|
Retinal Vessels | 1 | 2011 | 24 | 0.400 |
Why?
|
Cryopreservation | 1 | 2011 | 24 | 0.400 |
Why?
|
Embryonic Stem Cells | 1 | 2011 | 57 | 0.400 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 1 | 2011 | 17 | 0.400 |
Why?
|
Capillaries | 4 | 2012 | 29 | 0.400 |
Why?
|
Arterioles | 3 | 2015 | 18 | 0.390 |
Why?
|
Chemotaxis | 2 | 2011 | 57 | 0.390 |
Why?
|
Proteoglycans | 3 | 2018 | 46 | 0.390 |
Why?
|
Rats, Sprague-Dawley | 11 | 2016 | 1534 | 0.390 |
Why?
|
Algorithms | 4 | 2006 | 435 | 0.390 |
Why?
|
Vasa Vasorum | 2 | 2020 | 3 | 0.380 |
Why?
|
Glioma | 1 | 2011 | 76 | 0.380 |
Why?
|
Cell Membrane | 3 | 2014 | 360 | 0.380 |
Why?
|
Body Fluids | 1 | 2010 | 15 | 0.380 |
Why?
|
Hyperglycemia | 1 | 2011 | 53 | 0.370 |
Why?
|
Antigens, CD | 3 | 2016 | 116 | 0.370 |
Why?
|
Mitosis | 1 | 2010 | 97 | 0.370 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 2009 | 24 | 0.360 |
Why?
|
Membrane Proteins | 4 | 2011 | 486 | 0.360 |
Why?
|
Microscopy, Atomic Force | 2 | 2021 | 59 | 0.350 |
Why?
|
Cholesterol, LDL | 1 | 2009 | 63 | 0.350 |
Why?
|
Cell Proliferation | 2 | 2021 | 1149 | 0.340 |
Why?
|
Cell Line, Tumor | 4 | 2019 | 2128 | 0.340 |
Why?
|
Phosphorylation | 3 | 2021 | 878 | 0.340 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2011 | 157 | 0.330 |
Why?
|
RNA Interference | 4 | 2016 | 225 | 0.330 |
Why?
|
Mice, Knockout | 2 | 2021 | 897 | 0.330 |
Why?
|
Cell Culture Techniques | 4 | 2013 | 136 | 0.320 |
Why?
|
Finite Element Analysis | 2 | 2020 | 16 | 0.320 |
Why?
|
Mesentery | 2 | 2016 | 9 | 0.310 |
Why?
|
Linoleic Acids, Conjugated | 1 | 2007 | 2 | 0.310 |
Why?
|
Male | 17 | 2022 | 18870 | 0.300 |
Why?
|
Transport Vesicles | 1 | 2007 | 20 | 0.300 |
Why?
|
Carotid Sinus | 1 | 2006 | 1 | 0.290 |
Why?
|
Regional Blood Flow | 4 | 2020 | 47 | 0.290 |
Why?
|
Time Factors | 6 | 2016 | 1681 | 0.290 |
Why?
|
Adherens Junctions | 2 | 2017 | 8 | 0.280 |
Why?
|
Oxygen Consumption | 1 | 2006 | 98 | 0.280 |
Why?
|
Intracellular Fluid | 1 | 2005 | 26 | 0.280 |
Why?
|
Gels | 3 | 2011 | 41 | 0.280 |
Why?
|
Up-Regulation | 3 | 2016 | 490 | 0.280 |
Why?
|
Umbilical Veins | 1 | 2005 | 16 | 0.280 |
Why?
|
Hemorheology | 4 | 2006 | 6 | 0.270 |
Why?
|
Phenotype | 3 | 2016 | 650 | 0.260 |
Why?
|
Serum | 1 | 2004 | 13 | 0.260 |
Why?
|
Matrix Metalloproteinase 9 | 2 | 2016 | 88 | 0.250 |
Why?
|
Actins | 3 | 2014 | 142 | 0.250 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 33 | 0.250 |
Why?
|
Serum Albumin, Bovine | 1 | 2004 | 49 | 0.250 |
Why?
|
Protein Binding | 2 | 2021 | 913 | 0.250 |
Why?
|
Elastic Tissue | 1 | 2004 | 7 | 0.250 |
Why?
|
Diffusion | 4 | 2015 | 49 | 0.250 |
Why?
|
Muscle Contraction | 1 | 2004 | 63 | 0.250 |
Why?
|
Adipose Tissue | 2 | 2017 | 167 | 0.250 |
Why?
|
Blood Circulation | 1 | 2003 | 1 | 0.250 |
Why?
|
Homeostasis | 1 | 2005 | 172 | 0.240 |
Why?
|
Disease Models, Animal | 2 | 2021 | 1300 | 0.240 |
Why?
|
Membranes, Artificial | 1 | 2003 | 27 | 0.240 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2004 | 160 | 0.240 |
Why?
|
Water-Electrolyte Balance | 1 | 2003 | 17 | 0.240 |
Why?
|
Oxygen | 2 | 2020 | 193 | 0.240 |
Why?
|
Cadherins | 2 | 2014 | 82 | 0.240 |
Why?
|
Inflammation | 3 | 2022 | 577 | 0.230 |
Why?
|
Arteriosclerosis | 1 | 2003 | 35 | 0.230 |
Why?
|
Tissue Distribution | 3 | 2013 | 197 | 0.230 |
Why?
|
Neovascularization, Pathologic | 2 | 2020 | 122 | 0.230 |
Why?
|
Adenosine Triphosphate | 1 | 2004 | 180 | 0.230 |
Why?
|
Fluorescein | 2 | 2017 | 15 | 0.220 |
Why?
|
Gene Expression Profiling | 1 | 2006 | 600 | 0.220 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2022 | 58 | 0.220 |
Why?
|
Hypertension | 1 | 2009 | 770 | 0.210 |
Why?
|
Tight Junctions | 4 | 2010 | 24 | 0.210 |
Why?
|
Gene Knockdown Techniques | 2 | 2014 | 161 | 0.210 |
Why?
|
Neuronal Plasticity | 1 | 2022 | 102 | 0.210 |
Why?
|
Laser-Doppler Flowmetry | 4 | 2005 | 14 | 0.200 |
Why?
|
Collagen | 2 | 2013 | 162 | 0.200 |
Why?
|
Chondroitinases and Chondroitin Lyases | 2 | 2012 | 2 | 0.200 |
Why?
|
Dextrans | 4 | 2011 | 17 | 0.200 |
Why?
|
Hyaluronoglucosaminidase | 2 | 2012 | 19 | 0.200 |
Why?
|
Lipoproteins | 2 | 2016 | 61 | 0.200 |
Why?
|
Glucose | 2 | 2013 | 217 | 0.190 |
Why?
|
Enzyme Activation | 2 | 2014 | 423 | 0.190 |
Why?
|
Vascular Resistance | 1 | 2020 | 32 | 0.190 |
Why?
|
Rats, Wistar | 3 | 2005 | 202 | 0.190 |
Why?
|
Stents | 1 | 2020 | 59 | 0.190 |
Why?
|
Equipment Failure Analysis | 3 | 2004 | 42 | 0.190 |
Why?
|
Mice, Inbred C57BL | 4 | 2022 | 1530 | 0.190 |
Why?
|
Inflammation Mediators | 1 | 2021 | 120 | 0.180 |
Why?
|
Biological Transport, Active | 2 | 2011 | 25 | 0.180 |
Why?
|
Blotting, Western | 3 | 2011 | 834 | 0.180 |
Why?
|
Tissue Engineering | 1 | 2019 | 59 | 0.170 |
Why?
|
Hydrostatic Pressure | 4 | 2010 | 6 | 0.170 |
Why?
|
Microscopy | 2 | 2019 | 32 | 0.170 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2019 | 90 | 0.160 |
Why?
|
Osmotic Pressure | 3 | 2015 | 20 | 0.160 |
Why?
|
Microvessels | 2 | 2016 | 31 | 0.160 |
Why?
|
Age Factors | 1 | 2021 | 1007 | 0.160 |
Why?
|
Cell Division | 2 | 2009 | 296 | 0.160 |
Why?
|
omega-N-Methylarginine | 2 | 2015 | 4 | 0.160 |
Why?
|
Blood Proteins | 1 | 2018 | 65 | 0.160 |
Why?
|
NF-kappa B | 2 | 2022 | 306 | 0.160 |
Why?
|
Intracellular Space | 1 | 2017 | 35 | 0.160 |
Why?
|
Indicators and Reagents | 1 | 2017 | 57 | 0.150 |
Why?
|
Cilia | 1 | 2016 | 23 | 0.150 |
Why?
|
Sulfotransferases | 1 | 2016 | 7 | 0.150 |
Why?
|
Signal Transduction | 2 | 2016 | 1802 | 0.150 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2016 | 54 | 0.150 |
Why?
|
Factor Xa | 1 | 2016 | 3 | 0.150 |
Why?
|
Spheroids, Cellular | 1 | 2016 | 28 | 0.150 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2016 | 93 | 0.150 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2016 | 21 | 0.150 |
Why?
|
Gene Knockout Techniques | 1 | 2016 | 46 | 0.140 |
Why?
|
Thrombin | 1 | 2016 | 24 | 0.140 |
Why?
|
Blood Coagulation | 1 | 2016 | 22 | 0.140 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2013 | 605 | 0.140 |
Why?
|
Tumor Burden | 1 | 2016 | 79 | 0.140 |
Why?
|
Mice, SCID | 1 | 2016 | 143 | 0.140 |
Why?
|
Down-Regulation | 2 | 2011 | 420 | 0.140 |
Why?
|
Cell Differentiation | 2 | 2011 | 562 | 0.140 |
Why?
|
Biological Assay | 1 | 2016 | 56 | 0.140 |
Why?
|
Coculture Techniques | 2 | 2013 | 96 | 0.140 |
Why?
|
Platelet-Derived Growth Factor | 2 | 2007 | 31 | 0.140 |
Why?
|
Tunica Intima | 2 | 2007 | 21 | 0.140 |
Why?
|
Blood Platelets | 1 | 2016 | 74 | 0.140 |
Why?
|
Exocytosis | 1 | 2015 | 45 | 0.140 |
Why?
|
Physical Stimulation | 2 | 2006 | 26 | 0.140 |
Why?
|
Tumor Cells, Cultured | 1 | 2016 | 480 | 0.130 |
Why?
|
NG-Nitroarginine Methyl Ester | 2 | 2005 | 34 | 0.130 |
Why?
|
Microscopy, Video | 2 | 2005 | 9 | 0.130 |
Why?
|
Microscopy, Electron, Transmission | 2 | 2016 | 143 | 0.130 |
Why?
|
Cholesterol | 1 | 2016 | 194 | 0.130 |
Why?
|
Aquaporin 1 | 1 | 2015 | 8 | 0.130 |
Why?
|
Lipids | 1 | 2016 | 222 | 0.130 |
Why?
|
Sepsis | 1 | 2015 | 76 | 0.130 |
Why?
|
Focal Adhesions | 1 | 2014 | 15 | 0.130 |
Why?
|
Blood Cells | 1 | 2014 | 8 | 0.130 |
Why?
|
Caveolae | 1 | 2014 | 8 | 0.130 |
Why?
|
Immunohistochemistry | 1 | 2016 | 859 | 0.120 |
Why?
|
G(M1) Ganglioside | 1 | 2014 | 13 | 0.120 |
Why?
|
Adaptation, Physiological | 2 | 2005 | 106 | 0.120 |
Why?
|
Cell Shape | 1 | 2014 | 35 | 0.120 |
Why?
|
Caveolin 1 | 1 | 2014 | 27 | 0.120 |
Why?
|
Integrin alpha3 | 1 | 2013 | 1 | 0.120 |
Why?
|
Rhodamines | 2 | 2011 | 20 | 0.120 |
Why?
|
Anisotropy | 2 | 2020 | 24 | 0.120 |
Why?
|
Peptides | 1 | 2016 | 308 | 0.120 |
Why?
|
Reproducibility of Results | 3 | 2016 | 901 | 0.120 |
Why?
|
Gelatin | 1 | 2013 | 13 | 0.120 |
Why?
|
Glycoproteins | 1 | 2014 | 100 | 0.120 |
Why?
|
Phospholipids | 1 | 2014 | 68 | 0.120 |
Why?
|
Matrix Metalloproteinases | 1 | 2013 | 44 | 0.120 |
Why?
|
Macromolecular Substances | 2 | 2004 | 86 | 0.120 |
Why?
|
Enzyme Inhibitors | 2 | 2005 | 396 | 0.110 |
Why?
|
Software | 1 | 2014 | 204 | 0.110 |
Why?
|
Models, Theoretical | 1 | 2014 | 210 | 0.110 |
Why?
|
Cell Adhesion Molecules | 1 | 2013 | 70 | 0.110 |
Why?
|
Prosthesis Design | 4 | 2005 | 26 | 0.110 |
Why?
|
Electric Impedance | 3 | 2010 | 23 | 0.110 |
Why?
|
Adsorption | 1 | 2012 | 67 | 0.110 |
Why?
|
Elastic Modulus | 1 | 2012 | 17 | 0.110 |
Why?
|
Blood Vessels | 1 | 2012 | 32 | 0.110 |
Why?
|
Histocytochemistry | 1 | 2011 | 45 | 0.100 |
Why?
|
Microscopy, Fluorescence | 1 | 2012 | 240 | 0.100 |
Why?
|
Chemotactic Factors | 1 | 2011 | 7 | 0.100 |
Why?
|
Freeze Substitution | 1 | 2011 | 1 | 0.100 |
Why?
|
Body Water | 1 | 2011 | 26 | 0.100 |
Why?
|
In Situ Nick-End Labeling | 1 | 2011 | 126 | 0.100 |
Why?
|
Fluorescence | 1 | 2011 | 117 | 0.100 |
Why?
|
Binding Sites | 1 | 2012 | 597 | 0.100 |
Why?
|
Cell Survival | 2 | 2011 | 818 | 0.100 |
Why?
|
Paclitaxel | 1 | 2010 | 48 | 0.100 |
Why?
|
Neoplasm Invasiveness | 1 | 2011 | 247 | 0.090 |
Why?
|
Diet | 1 | 2016 | 747 | 0.090 |
Why?
|
Microscopy, Confocal | 4 | 2015 | 210 | 0.090 |
Why?
|
Genes, fos | 1 | 2009 | 14 | 0.090 |
Why?
|
Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2009 | 7 | 0.090 |
Why?
|
Flavonoids | 1 | 2010 | 78 | 0.090 |
Why?
|
Amino Acid Chloromethyl Ketones | 1 | 2009 | 7 | 0.090 |
Why?
|
Transcription Factor AP-1 | 1 | 2009 | 33 | 0.090 |
Why?
|
Transforming Growth Factor beta | 1 | 2011 | 183 | 0.090 |
Why?
|
Cycloheximide | 1 | 2009 | 30 | 0.090 |
Why?
|
Polymers | 1 | 2010 | 117 | 0.090 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 2009 | 14 | 0.090 |
Why?
|
Polymerase Chain Reaction | 1 | 2011 | 430 | 0.090 |
Why?
|
Heparin Lyase | 1 | 2009 | 2 | 0.090 |
Why?
|
Pronase | 1 | 2009 | 4 | 0.090 |
Why?
|
Cell Separation | 1 | 2009 | 91 | 0.090 |
Why?
|
Carrier Proteins | 1 | 2011 | 287 | 0.090 |
Why?
|
Dipeptides | 1 | 2009 | 29 | 0.090 |
Why?
|
Protease Inhibitors | 1 | 2009 | 47 | 0.090 |
Why?
|
Necrosis | 1 | 2009 | 45 | 0.090 |
Why?
|
DNA Primers | 1 | 2009 | 269 | 0.090 |
Why?
|
Gene Silencing | 1 | 2009 | 143 | 0.090 |
Why?
|
Mitral Valve | 2 | 2005 | 22 | 0.080 |
Why?
|
Enzymes | 1 | 2008 | 30 | 0.080 |
Why?
|
Blood-Brain Barrier | 1 | 2010 | 153 | 0.080 |
Why?
|
Pigment Epithelium of Eye | 1 | 2008 | 32 | 0.080 |
Why?
|
Predictive Value of Tests | 1 | 2009 | 424 | 0.080 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2013 | 781 | 0.080 |
Why?
|
RNA | 1 | 2009 | 234 | 0.080 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2004 | 67 | 0.080 |
Why?
|
Smooth Muscle Myosins | 1 | 2007 | 1 | 0.080 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2009 | 325 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2007 | 9 | 0.080 |
Why?
|
Connective Tissue | 1 | 2007 | 9 | 0.080 |
Why?
|
N-Acetylneuraminic Acid | 1 | 2007 | 7 | 0.080 |
Why?
|
Materials Testing | 2 | 2005 | 71 | 0.080 |
Why?
|
Myosin Heavy Chains | 1 | 2007 | 19 | 0.080 |
Why?
|
Prosthesis Failure | 2 | 2003 | 10 | 0.080 |
Why?
|
Hyperplasia | 1 | 2007 | 38 | 0.080 |
Why?
|
Computational Biology | 1 | 2009 | 275 | 0.070 |
Why?
|
PPAR gamma | 1 | 2007 | 49 | 0.070 |
Why?
|
PPAR alpha | 1 | 2007 | 42 | 0.070 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 2005 | 59 | 0.070 |
Why?
|
Brain | 3 | 2023 | 1268 | 0.070 |
Why?
|
Elasticity | 2 | 2007 | 38 | 0.070 |
Why?
|
Models, Chemical | 1 | 2007 | 201 | 0.070 |
Why?
|
Rabbits | 1 | 2006 | 278 | 0.070 |
Why?
|
Surface Properties | 1 | 2006 | 121 | 0.070 |
Why?
|
Blood Volume | 1 | 2005 | 5 | 0.070 |
Why?
|
Xanthenes | 1 | 2005 | 11 | 0.070 |
Why?
|
Acoustics | 1 | 2005 | 11 | 0.070 |
Why?
|
Carbon Dioxide | 1 | 2005 | 78 | 0.070 |
Why?
|
Flow Injection Analysis | 1 | 2004 | 2 | 0.060 |
Why?
|
Sonication | 1 | 2004 | 15 | 0.060 |
Why?
|
Osmosis | 1 | 2004 | 7 | 0.060 |
Why?
|
Filtration | 1 | 2004 | 14 | 0.060 |
Why?
|
Fluorescent Dyes | 1 | 2005 | 173 | 0.060 |
Why?
|
Solvents | 1 | 2004 | 93 | 0.060 |
Why?
|
Muscle, Smooth | 1 | 2004 | 51 | 0.060 |
Why?
|
Thrombosis | 1 | 2004 | 61 | 0.060 |
Why?
|
Bradykinin | 1 | 2003 | 22 | 0.060 |
Why?
|
Thromboembolism | 1 | 2003 | 14 | 0.060 |
Why?
|
Histamine | 1 | 2003 | 17 | 0.060 |
Why?
|
Physics | 1 | 2023 | 2 | 0.060 |
Why?
|
Mitral Valve Insufficiency | 1 | 2003 | 15 | 0.060 |
Why?
|
Blood Pressure Determination | 1 | 2003 | 53 | 0.060 |
Why?
|
Head | 1 | 2023 | 30 | 0.060 |
Why?
|
Skin | 1 | 2004 | 173 | 0.060 |
Why?
|
Sulfates | 1 | 2022 | 23 | 0.060 |
Why?
|
Muscle, Skeletal | 1 | 2004 | 257 | 0.050 |
Why?
|
Calcium | 1 | 2004 | 445 | 0.050 |
Why?
|
Apolipoproteins E | 1 | 2022 | 129 | 0.050 |
Why?
|
Perfusion | 2 | 2012 | 31 | 0.050 |
Why?
|
Transfection | 2 | 2015 | 496 | 0.050 |
Why?
|
Stochastic Processes | 1 | 2019 | 10 | 0.040 |
Why?
|
Female | 5 | 2022 | 19873 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2012 | 164 | 0.040 |
Why?
|
Antithrombins | 1 | 2016 | 3 | 0.040 |
Why?
|
Heparin | 1 | 2016 | 34 | 0.040 |
Why?
|
Hair | 1 | 2015 | 20 | 0.030 |
Why?
|
Chromatography, Liquid | 1 | 2016 | 140 | 0.030 |
Why?
|
Lysosomes | 1 | 2015 | 80 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2015 | 185 | 0.030 |
Why?
|
Fluoresceins | 1 | 2015 | 27 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2016 | 255 | 0.030 |
Why?
|
Phosphoproteins | 2 | 2008 | 154 | 0.030 |
Why?
|
Lipopolysaccharides | 1 | 2015 | 200 | 0.030 |
Why?
|
Kinetics | 1 | 2015 | 650 | 0.030 |
Why?
|
Cations | 1 | 2010 | 44 | 0.020 |
Why?
|
Nitrates | 1 | 2010 | 35 | 0.020 |
Why?
|
Drug Evaluation | 1 | 2010 | 9 | 0.020 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2008 | 35 | 0.020 |
Why?
|
Electroporation | 1 | 2008 | 18 | 0.020 |
Why?
|
Lung | 1 | 2010 | 413 | 0.020 |
Why?
|
Partial Pressure | 1 | 2005 | 7 | 0.020 |
Why?
|
Models, Structural | 1 | 2005 | 8 | 0.020 |
Why?
|
Resins, Synthetic | 1 | 2005 | 1 | 0.020 |
Why?
|
Solubility | 1 | 2005 | 115 | 0.020 |
Why?
|
Mechanics | 1 | 2005 | 3 | 0.020 |
Why?
|
Photography | 1 | 2005 | 46 | 0.020 |
Why?
|
Biocompatible Materials | 1 | 2005 | 75 | 0.020 |
Why?
|
DNA | 1 | 2008 | 549 | 0.020 |
Why?
|
Administration, Cutaneous | 1 | 2004 | 38 | 0.020 |
Why?
|
Carbon | 1 | 2005 | 95 | 0.020 |
Why?
|
Equipment Design | 1 | 2004 | 127 | 0.020 |
Why?
|
Ultrasonography | 1 | 2004 | 115 | 0.020 |
Why?
|
Cytochalasin D | 1 | 2003 | 3 | 0.020 |
Why?
|
Colchicine | 1 | 2003 | 15 | 0.020 |
Why?
|
Particle Size | 1 | 2004 | 200 | 0.010 |
Why?
|
Serum Albumin | 1 | 2003 | 49 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2004 | 528 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2003 | 555 | 0.010 |
Why?
|